Comment
doi: 10.1001/jamaoncol.2015.2733.
Chemotherapy--A Viable Partner for Cancer Immunotherapy?
Affiliations
- PMID: 26291503
- DOI: 10.1001/jamaoncol.2015.2733
Item in Clipboard
Comment
Chemotherapy--A Viable Partner for Cancer Immunotherapy?
JAMA Oncol.
2015 Nov.
No abstract available
Comment on
-
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.JAMA Oncol. 2015 Nov;1(8):1087-95. doi: 10.1001/jamaoncol.2015.2736. JAMA Oncol. 2015. PMID: 26291768 Free PMC article. Clinical Trial.
Similar articles
-
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.N Engl J Med. 2010 Nov 11;363(20):1966; author reply 1967-8. doi: 10.1056/NEJMc1009982. N Engl J Med. 2010. PMID: 21067392 No abstract available.
-
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.N Engl J Med. 2010 Nov 11;363(20):1966-7; author reply 1968. doi: 10.1056/NEJMc1009982. N Engl J Med. 2010. PMID: 21067391 No abstract available.
-
Have we reached a plateau in adjuvant breast cancer therapy?Lancet. 2009 Oct 24;374(9699):1421. doi: 10.1016/S0140-6736(09)61862-6. Lancet. 2009. PMID: 19854372 No abstract available.
-
Current immunotherapeutic strategies in breast cancer.Surg Oncol Clin N Am. 2007 Oct;16(4):841-60, ix. doi: 10.1016/j.soc.2007.07.008. Surg Oncol Clin N Am. 2007. PMID: 18022548 Review.
-
[Promising on advanced cancer, several new drugs coming].Lakartidningen. 2012 Feb 22-28;109(8):416-9. Lakartidningen. 2012. PMID: 22509668 Review. Swedish. No abstract available.
Cited by
-
Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer.Mol Imaging Biol. 2021 Oct;23(5):714-723. doi: 10.1007/s11307-021-01596-y. Epub 2021 Mar 12. Mol Imaging Biol. 2021. PMID: 33713000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
